Developing an efficacious diclofenac diethylamine transdermal formulation

Journal of Food and Drug Analysis

Volumn 20, Issue 2, 2012, Pages

  Shah, Syed Nisar Hussain ^a   Mehboob E Rabbani, ^a   Shahzad, Yasser ^b   Badshah, Amir ^c   Meidan, Victor M ^d   Murtaza, Ghulam ^e  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^b UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^c UNIVERSITY OF PESHAWAR   (Pakistan)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^e COMSATS Institute of Information Technology ^*  (Pakistan)

Author keywords

Diclofenac diethylamine; Lotion; Oleic acid; Percutaneous absorption; Transdermal

Indexed keywords

DICLOFENAC DIETHYLAMINE; OLEIC ACID; SILICON; TURPENTINE OIL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENCY; DRUG POTENTIATION; DRUG STABILITY; DRUG TRANSPORT; ERYTHEMA; EXPERIMENTAL RABBIT; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INFLAMMATION; LOTION; MALE; NONHUMAN; NORMAL HUMAN; PAW EDEMA; PH; RAT; SKIN IRRITATION; SKIN PERMEABILITY; SKIN SENSATION; TAIL FLICK TEST; TOXICITY TESTING; VISCOSITY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 84866113739     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.6227/jfda.2012200205     Document Type: Article

References (31)

1. Gan, T. J. 2010. Diclofenac: an update on its mechanism of action and safety profile. Curr. Med. Res. Opin. 26: 1715-1731.
2. Niethard, F. U., Gold, M. S., Solomon, G. S., Liu, J. M., Unkauf, M., Albrecht, H. H. and Elkik, F. 2005. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J. Rheumatol. 32: 2384-2392.
3. Kulkarni, R. V., Wagh, Y. J., Setty, C. M. and Sa, B. 2011. Development and characterization of sodium alginate-hydroxypropyl methylcellulose-polyester multilayered hydrogel membranes for drug delivery through skin. Polymer-Plastics Technol. Engin. 50: 490-497.
4. Minghetti, P., Cilurzo, F., Casiraghi, A., Montanari, L. and Fini, A. 2007. Ex vivo study of transdermal permeation of four diclofenac salts from different vehicles. J. Pharm. Sci. 96: 814-823.
5. Arora, P. and Mukherjee, B. 2002. Design, development, physicochemical, and In vitro and In vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J. Pharm. Sci. 91: 2089-2096.
6. Meidan, V. M. and Michniak, B. B. 2004. Emerging technologies in transdermal therapeutics. Am. J. Ther. 11: 312-316.
7. Djordjevic, L., Primorac, M., Stupar, M. and Krajisnik, D. 2004. Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug. Int. J. Pharm. 271: 9-11.
8. Kweon, J. H., Chi, S. C. and Park, E. S. 2004. Transdermal delivery of diclofenac using microemulsions. Arch. Pharm. Res. 27: 351-356.
9. Vucinić-Milanković, N., Savić, S., Vuleta, G. and Vucinić, S. 2007. The physicochemical characterization and In vitro/In vivo evaluation of natural surfactants-based emulsions as vehicles for diclofenac diethylamine. Drug Dev. Ind. Pharm. 33: 221-234.
10. Manosroi, A., Jantrawut, P. and Manosroi, J. 2008. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int. J. Pharm. 360: 156-163.
11. Khalil, E., Najjar, S. and Sallam, A. 2000. Aqueous solubility of diclofenac diethylamine in the presence of pharmaceutical additives: a comparative study with diclofenac sodium. Drug Dev. Ind. Pharm. 26: 375-381.
12. Baboota, S., Shakeel, F. and Kohli, K. 2006. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine. Methods Find. Exp. Clin. Pharmacol. 28: 109-114.
13. Zhao, L., Li, Y., Fang, L., Ren, C., Xu, Y. and He, Z. 2009. Effect of O-acylmenthol and salt formation on the skin permeation of diclofenac acid. Drug Dev. Ind. Pharm. 35: 814-826.
14. Chaudhary, H., Kohli, K., Amin, S., Rathee, P. and Kumar, V. 2011. Optimization and formulation design of gels of Diclofenac and Curcumin for transdermal drug delivery by Box-Behnken statistical design. J. Pharm. Sci. 100: 580-593.
15. Yariv, D., Efrat, R., Libster, D., Aserin, A. and Garti, N. 2010. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems. Colloids and Surf B: Biointerfaces. 78: 185-192.
16. Rubio, L., Alonso, C., Rodriguez, G., Barbosa-Barros, L., Cordech, L., De la Maza, A., Parra, J. L. and López, O. 2010. Bicellar systems for In vitro percutaneous absorption of diclofenac. Int. J. Pharm. 386: 108-113.
17. Pathan, I. B. and Setty, C. M. 2009. Chemical Penetration Enhancers for Transdermal Drug Delivery Systems. Trop. J. Pharm. Res. 8: 173-179.
18. Gupta, G. D. and Gound, R. S. 1999. Release rate of nimesulide from different gellants. Indian J. Pharm. Sci. 61: 229-230.
19. Meidan, V. M. and Pritchard, D. 2010. A two-layer diffusive model for describing the variability of transdermal drug permeation. Eur. J. Pharm. Biopharm. 74: 513-517.
20. Shah, S. N. H., Mahboob Rabbani, Muhammad Fakhruddin Amir. 2005. In vitro study of percutaneous absorption of diclofenac in the presence of sodium lauryl sulphate through rabbit skin. J. Res. Sci. 16: 45-50.
21. Ng, S. F., Rouse, J. J., Sanderson, F. D., Meidan, V. and Eccleston, G. M. 2010. Validation of a static Franz diffusion cell system for In vitro permeation studies. AAPS PharmSci. Tech. 11: 1432-1441.
22. Adeyemi, O. O., Okpo, S. O. and Ogunti, O. O. 2002. Analgesic and anti-inflammatory effects of the aqueous extract of leaves of Persea americana Mill (Lauraceae). Fitoterapia. 73: 375-380.
23. Bamgbose, S. O. and Noamesi, B. K. 1981. Studies on cryptolepine II: Inhibition of carrageenan induced oedema by cryptolepine. Planta Med. 41: 392-396.
24. Sewell, R. D. and Spencer, P. S. 1976. Antinociceptive activity of narcotic agonist and partial agonist analgesics and other agents in the tail-immersion test in mice and rats. Neuropharmacology 15: 683-688.
25. Rice, D. P. and Ketterer, D. J. 1977. Restrainer and cell for dermal dosing of small laboratory animals. Lab. Anim. Sci. 27: 72-75.
26. Ngo, M. A. and Maibach, H. I.2010. Dermatotoxicology: Historical perspective and advances. Toxicol. Appl. Pharmacol. 243: 225-238.
27. European Medicines Agency. ICH Topic E 6 (R1) Guideline for Good Clinical Practice. Step 5. Note for guidance on good clinical practice (CPMP/ICH/135/95). Accessed on January 2 (2009). www.ema.euro-pa.eu/pdfs/human/ ich/013595en.pdf.
28. World Medical Association Declaration of Helsinki. Ethical principles of medical research involving human subjects. Accessed on September 3 (2008). http://www.wma.net/en/30publications/10policies/b3/index.html.
29. El Maghraby, G. M. M., Williams, A. C. and Barry, B. W. 2001. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J. Pharm. Pharmacol. 53:1069-1077.
30. Boelsma, E., Hendriks, H. F. J. and Roza, L. 2001. Nutritional skin care: health effects of micronutrients and fatty acids. Am. J. Clin. Nutr. 73: 853-864.
31. Rowat, A. C., Kitson, N. and Thewalt, J. L. 2006. Interactions of oleic acid and model stratum corneum membranes as seen by 2H NMR. Int. J. Pharm. 307: 225-331.